Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1Phase 1 1

Status

Completed 77Unknown 38Recruiting 18Terminated 15Active not recruiting 11Withdrawn 1Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Leukemia 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Tissue Adhesions 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Ovarian Cysts 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1NSCLC 1Multiple Myeloma 1Mucositis 1Malnutrition 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioblastoma 1Fatigue 1Fasting Mimicking Diet 1Eyelid Squamous Cell Carcinoma 1Endometriosis 1

Interventions

sargramostim 1Vincristine 1Rituximab 1Prednisone 1Methods 1Immunotherapy, Active 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Coal Tar 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Lymphoma, Large B-Cell, Diffuse × Clear all
NCT00324831 2013-12-18

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

National Cancer Institute (NCI)

Phase 3 Suspended
480 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡